Most cited article - PubMed ID 37938781
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Tick-borne encephalitis (TBE) virus (TBEV) is transmitted to humans via tick bites. Infection is benign in >90% of the cases but can cause mild (<5%), moderate (<4%), or severe (<1%) encephalitis. We show here that ∼10% of patients hospitalized for severe TBE in cohorts from Austria, Czech Republic, and France carry auto-Abs neutralizing IFN-α2, -β, and/or -ω at the onset of disease, contrasting with only ∼1% of patients with moderate and mild TBE. These auto-Abs were found in two of eight patients who died and none of 13 with silent infection. The odds ratios (OR) for severe TBE in individuals with these auto-Abs relative to those without them in the general population were 4.9 (95% CI: 1.5-15.9, P < 0.0001) for the neutralization of only 100 pg/ml IFN-α2 and/or -ω, and 20.8 (95% CI: 4.5-97.4, P < 0.0001) for the neutralization of 10 ng/ml IFN-α2 and -ω. Auto-Abs neutralizing type I IFNs accounted for ∼10% of severe TBE cases in these three European cohorts.
- MeSH
- Autoantibodies * immunology MeSH
- Adult MeSH
- Interferon Type I * immunology MeSH
- Encephalitis, Tick-Borne * immunology MeSH
- Middle Aged MeSH
- Humans MeSH
- Antibodies, Neutralizing * immunology MeSH
- Aged MeSH
- Encephalitis Viruses, Tick-Borne immunology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
- Austria epidemiology MeSH
- Names of Substances
- Autoantibodies * MeSH
- Interferon Type I * MeSH
- Antibodies, Neutralizing * MeSH